PL3119745T3 - Sposób wytwarzania związku przeciwgrzybiczego - Google Patents

Sposób wytwarzania związku przeciwgrzybiczego

Info

Publication number
PL3119745T3
PL3119745T3 PL15764743T PL15764743T PL3119745T3 PL 3119745 T3 PL3119745 T3 PL 3119745T3 PL 15764743 T PL15764743 T PL 15764743T PL 15764743 T PL15764743 T PL 15764743T PL 3119745 T3 PL3119745 T3 PL 3119745T3
Authority
PL
Poland
Prior art keywords
antifungal compound
compound process
antifungal
compound
Prior art date
Application number
PL15764743T
Other languages
English (en)
Inventor
William J. Hoekstra
Christopher M. Yates
Mark Behnke
Asaf Alimardanov
Scott A. David
Douglas Franklin Fry
Original Assignee
Mycovia Pharmaceuticals, Inc.
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mycovia Pharmaceuticals, Inc., The U.S.A. As Represented By The Secretary, Department Of Health And Human Services filed Critical Mycovia Pharmaceuticals, Inc.
Publication of PL3119745T3 publication Critical patent/PL3119745T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26—Radicals substituted by halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Artificial Filaments (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PL15764743T 2014-03-19 2015-03-19 Sposób wytwarzania związku przeciwgrzybiczego PL3119745T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461955615P 2014-03-19 2014-03-19
PCT/US2015/021491 WO2015143172A1 (en) 2014-03-19 2015-03-19 Antifungal compound process
EP15764743.9A EP3119745B1 (en) 2014-03-19 2015-03-19 Antifungal compound process

Publications (1)

Publication Number Publication Date
PL3119745T3 true PL3119745T3 (pl) 2021-01-25

Family

ID=54145323

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15764743T PL3119745T3 (pl) 2014-03-19 2015-03-19 Sposób wytwarzania związku przeciwgrzybiczego

Country Status (14)

Country Link
US (2) US10173998B2 (pl)
EP (1) EP3119745B1 (pl)
JP (1) JP6509897B2 (pl)
KR (1) KR102151082B1 (pl)
CN (2) CN109970629B (pl)
AU (1) AU2015231226B2 (pl)
BR (1) BR112016020937B1 (pl)
CA (1) CA2942968C (pl)
EA (1) EA037587B1 (pl)
ES (1) ES2815373T3 (pl)
HU (1) HUE052446T2 (pl)
MX (1) MX365494B (pl)
PL (1) PL3119745T3 (pl)
WO (1) WO2015143172A1 (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10077250B2 (en) * 2014-03-19 2018-09-18 Mycovia Pharmaceuticals, Inc. Antifungal compound process
US9981943B2 (en) * 2014-03-19 2018-05-29 Mycovia Pharmaceuticals, Inc. Antifungal compound process
CN109678791B (zh) 2014-03-19 2022-07-01 美国陶氏益农公司 1-(2,4-二氟苯)-2,2-二氟-2-(5-取代吡啶-2-基)乙酮及制备方法
EP3119748A4 (en) 2014-03-19 2017-08-30 Viamet Pharmaceuticals, Inc. Antifungal compound process
US10000465B2 (en) 2014-03-19 2018-06-19 Mycovia Pharmaceuticals, Inc. Antifungal compound process
JP6613391B2 (ja) 2014-03-19 2019-12-04 ブイピーエス‐3,インコーポレイテッド 2−(2,4−ジフルオロフェニル)−1,1−ジフルオロ−1−(5−置換ピリジン−2−イル)−3−(1h−テトラゾール−1−イル)プロパン−2−オールおよびその調製工程
EP3119754A4 (en) 2014-03-19 2017-12-13 Viamet Pharmaceuticals, Inc. Antifungal compound process
EP3119746A4 (en) 2014-03-19 2017-08-16 Viamet Pharmaceuticals, Inc. Antifungal compound process
PL3271347T3 (pl) 2015-03-19 2022-11-21 Mycovia Pharmaceuticals, Inc. Związki przeciwgrzybicze i sposoby wytwarzania
EP3349753A4 (en) * 2015-09-18 2019-01-23 VPS-3, Inc. FUNGICIDE COMPOUNDS AND METHOD OF PREPARING THEREOF
BR112020009446A2 (pt) 2017-11-13 2020-11-03 Bayer Aktiengesellschaft derivados de tetrazólio propila e seu uso como fungicida
WO2020041200A1 (en) 2018-08-18 2020-02-27 Boragen Inc. Solid forms of substituted benzoxaborole and compositions thereof
CN114573557B (zh) * 2022-03-28 2024-03-08 浙江天宇药业股份有限公司 一种奥特康唑的制备方法
CN116621816B (zh) * 2022-09-23 2025-07-04 北京莱瑞森医药科技有限公司 一种伏立康唑对映异构对b的拆分方法
CN116675672B (zh) * 2023-06-05 2025-04-25 北京康立生医药技术开发有限公司 一种抗真菌药物的制备方法
CN119798219B (zh) * 2025-01-13 2025-07-18 长治医学院 一种奥特康唑的制备方法

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2854015B2 (de) 1978-12-14 1980-10-09 Dynamit Nobel Ag, 5210 Troisdorf Verfahren zur Herstellung von !H-TetrazoI-1-essigsauren und bestimmter Ester derselben
JP2000344744A (ja) 1999-06-04 2000-12-12 Ss Pharmaceut Co Ltd アセトフェノン誘導体およびその製法
US8198448B2 (en) 2006-07-14 2012-06-12 Amgen Inc. Fused heterocyclic derivatives and methods of use
KR100889937B1 (ko) 2007-08-06 2009-03-20 한미약품 주식회사 보리코나졸의 제조방법
KR101109215B1 (ko) 2009-06-17 2012-01-30 보령제약 주식회사 보리코나졸의 신규 중간체 및 이를 이용한 보리코나졸의 제조방법
EP2443099A1 (en) 2009-06-18 2012-04-25 Basf Se Antifungal 1, 2, 4-triazolyl derivatives having a 5- sulfur substituent
AU2011242562B2 (en) 2010-04-24 2016-10-13 Mycovia Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
US8809378B2 (en) 2011-06-19 2014-08-19 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
CN105884743B (zh) 2011-06-19 2019-08-06 威尔金制药(Nc)有限公司 金属酶抑制剂化合物
EA201490052A1 (ru) 2011-06-23 2014-04-30 Вайамет Фармасьютикалс, Инк. Соединения, ингибирующие металлоферменты
EP3351541A1 (en) 2011-12-11 2018-07-25 Viamet Pharmaceuticals (NC), Inc. Metalloenzyme inhibitor compounds
BR112014017799A8 (pt) 2012-01-20 2017-07-11 Viamet Pharmaceuticals Inc Compostos inibidores de metaloenzima
EA026209B1 (ru) 2012-01-20 2017-03-31 Ваймет Фармасьютикалс, Инк. Соединения, ингибирующие металлоферменты
WO2014043376A1 (en) 2012-09-12 2014-03-20 Dow Agrosciences Llc Metalloenzyme inhibitor compounds
AU2014209107B2 (en) 2013-01-28 2018-04-12 Viamet Pharmaceuticals (NC), Inc. Metalloenzyme inhibitor compounds
WO2014165861A1 (en) 2013-04-05 2014-10-09 The Regents Of The University Of California Metal-catalyzed coupling of aryl and vinyl halides with alpha, alpha-difluorocarbonyl compounds
HK1223093A1 (zh) 2013-05-28 2017-07-21 Viamet Pharmaceuticals (NC), Inc. 杀真菌组合物
JP6386035B2 (ja) 2013-06-12 2018-09-05 ヴィアメット ファーマスーティカルズ(エヌシー),インコーポレイテッド 金属酵素阻害剤化合物
EP3119748A4 (en) 2014-03-19 2017-08-30 Viamet Pharmaceuticals, Inc. Antifungal compound process
EP3119754A4 (en) 2014-03-19 2017-12-13 Viamet Pharmaceuticals, Inc. Antifungal compound process
JP6613391B2 (ja) 2014-03-19 2019-12-04 ブイピーエス‐3,インコーポレイテッド 2−(2,4−ジフルオロフェニル)−1,1−ジフルオロ−1−(5−置換ピリジン−2−イル)−3−(1h−テトラゾール−1−イル)プロパン−2−オールおよびその調製工程
US9981943B2 (en) 2014-03-19 2018-05-29 Mycovia Pharmaceuticals, Inc. Antifungal compound process
US10000465B2 (en) 2014-03-19 2018-06-19 Mycovia Pharmaceuticals, Inc. Antifungal compound process
EP3119749A4 (en) 2014-03-19 2017-12-13 Viamet Pharmaceuticals, Inc. Antifungal compound process
EP3119746A4 (en) 2014-03-19 2017-08-16 Viamet Pharmaceuticals, Inc. Antifungal compound process
CN109678791B (zh) 2014-03-19 2022-07-01 美国陶氏益农公司 1-(2,4-二氟苯)-2,2-二氟-2-(5-取代吡啶-2-基)乙酮及制备方法
US10077250B2 (en) * 2014-03-19 2018-09-18 Mycovia Pharmaceuticals, Inc. Antifungal compound process
PL3271347T3 (pl) 2015-03-19 2022-11-21 Mycovia Pharmaceuticals, Inc. Związki przeciwgrzybicze i sposoby wytwarzania
JP6908533B2 (ja) 2015-05-18 2021-07-28 マイコヴィア ファーマシューティカルズ,インコーポレイテッド 抗真菌性化合物
EP3349753A4 (en) 2015-09-18 2019-01-23 VPS-3, Inc. FUNGICIDE COMPOUNDS AND METHOD OF PREPARING THEREOF
EP3376866A4 (en) 2015-11-17 2019-04-10 Dow Agrosciences LLC 4 - ((6- (2- (2,4-DIFLUORPHENYL) -1,1-DIFLUOR-2-OXOETHYL) PYRIDIN-3-YL) BENZONITRIL AND METHOD OF PREPARING THEREOF
JP2018533635A (ja) 2015-11-17 2018-11-15 ダウ アグロサイエンシィズ エルエルシー 4−((6−(2−(2,4−ジフルオロフェニル)−1,1−ジフルオロ−2−ヒドロキシ−3−(1h−1,2,4−トリアゾ−ル−1−イル)プロピル)ピリジン−3−イル)オキシ)ベンゾニトリル及び製造方法
BR112018009920A2 (pt) 2015-11-17 2018-11-13 Dow Agrosciences Llc 4-((6-(2-(2,4-difluorfenil)-1,1-diflúor-2-hidróxi-3-(1h-1,2,4-triazol-1-il)propil)piridin-3-il)óxi)benzonitrila e processos de preparação
KR20180101342A (ko) 2015-11-17 2018-09-12 다우 아그로사이언시즈 엘엘씨 4-((6-(2-(2,4-디플루오로페닐)-1,1-디플루오로-2-히드록시-3-(1h-1,2,4-트리아졸-1-일)프로필)피리딘-3-일)옥시)벤조니트릴 및 제조방법
WO2017117393A1 (en) 2015-12-30 2017-07-06 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds

Also Published As

Publication number Publication date
JP2017509644A (ja) 2017-04-06
AU2015231226A1 (en) 2016-10-06
EP3119745B1 (en) 2020-08-05
MX2016012056A (es) 2017-04-27
US10173998B2 (en) 2019-01-08
MX365494B (es) 2019-06-05
HUE052446T2 (hu) 2021-04-28
US20170088539A1 (en) 2017-03-30
US20190161469A1 (en) 2019-05-30
BR112016020937B1 (pt) 2022-09-20
WO2015143172A1 (en) 2015-09-24
KR20160138012A (ko) 2016-12-02
CN106458900A (zh) 2017-02-22
EA037587B1 (ru) 2021-04-19
EP3119745A1 (en) 2017-01-25
BR112016020937A2 (pl) 2017-08-15
CA2942968C (en) 2022-03-15
US10392365B2 (en) 2019-08-27
EA201691649A1 (ru) 2016-12-30
CN109970629A (zh) 2019-07-05
CN106458900B (zh) 2019-01-01
CN109970629B (zh) 2023-04-11
JP6509897B2 (ja) 2019-05-08
AU2015231226B2 (en) 2019-04-04
CA2942968A1 (en) 2015-09-24
EP3119745A4 (en) 2017-08-23
ES2815373T3 (es) 2021-03-29
KR102151082B1 (ko) 2020-09-03

Similar Documents

Publication Publication Date Title
ZA201707783B (en) Antifungal compounds
ZA201801404B (en) Antifungal compound process
AP2017009836A0 (en) Aminopyridyloxypyrazole compounds
GB201411418D0 (en) Compounds
GB201417002D0 (en) Novel compound
HUE052446T2 (hu) Eljárás gombaellenes vegyület elõállítása céljából
EP3119755A4 (en) Antifungal compound process
EP3119754A4 (en) Antifungal compound process
GB201410430D0 (en) Compounds
GB201402431D0 (en) Compounds
EP3119746A4 (en) Antifungal compound process
EP3119748A4 (en) Antifungal compound process
EP3119749A4 (en) Antifungal compound process
EP3119771A4 (en) Antifungal compound process
EP3119764A4 (en) Antifungal compound process
GB201406591D0 (en) Compounds
GB201406956D0 (en) Compounds
GB201404987D0 (en) Compounds
GB201412660D0 (en) Compounds
GB201413695D0 (en) Compound
AP2017009778A0 (en) Azetidinyloxyphenylpyrrolidine compounds
PT3157902T (pt) Novos compostos de sulfonilaminobenzamida
GB201412238D0 (en) Compound
GB201407694D0 (en) Compound
GB201407506D0 (en) Novel compound